What a buyer sees
SYNTHESIS MED CHEM (UK) LIMITED
Research and experimental development on biotechnology · London · 07624460
5staff · FY2025
15years trading
—oldest owner on file
£230kcash at bank
Your turnover is on public record
filed£629kfor the year to 2025
Unusual at this size, and it works in your favour: a buyer is reading your number rather than guessing at one.
What your filings show moving
Staff5
20213 → 52025
Cash at bank£230k
2021£583k → £230k2025
How you sit in your trade
slowest tenth typical fastest tenth youSales per employee£125,820in the middle half
£28,358£136,156£699,758
Debtor daysdays43in the middle half
1457178
Creditor daysdays4
1126130
Stock daysdaysnot on your filings
632182
Each spread is companies in the same trade and size that did publish a turnover. Creditor days are shown but not marked: neither end of that one is plainly good.
What a buyer would ask 1
- No website on file against the companyThe first thing anyone does with a company number is look for the business behind it. Finding nothing is its own answer.
What a buyer would like 1
- Headcount grew from 4 to 5Growth a buyer can verify without asking you for anything.
What the register says
Owners
Nobody recorded with significant control.
Directors
- 56since 2011
- 68since 2022
- 38since 2023
| Year to | Filed | Turnover | Staff | Cash |
|---|---|---|---|---|
| 2025-12-31 | 2026-09-04 | £629k | 5 | £230k |
| 2023-12-31 | — | £1.1M | 4 | £1.3M |
| 2022-06-30 | — | £410k | 1 | £802k |
| 2021-06-30 | — | £426k | 3 | £583k |
A rough bracket, and why it is only that
0.4–0.9× sales£250k£570k
The turnover range is fitted on UK companies that did file one. The multiple is a published sector average from Dutch mid-market deals, not from your own numbers and not from your own market. Treat this as the opening bracket of a conversation, not a valuation.